Reducing mortality and morbidity in patients with severe COVID-19 disease by advancing ongoing trials of Mesenchymal Stromal (stem) Cell (MSC) therapy — Achieving global consensus and visibility for cellular host-directed therapies

Alimuddin Zumla, Fu Sheng Wang, Chao Chang, Giuseppe Ippolito, Nicola Petrosillo, Chiara Agrati, Esam I. Azhar, Sherif A. El-Kafrawy, Mohamed Osman, Laurence Zitvogel, Peter R. Galle, Franco Locatelli, Ellen Gorman, Cecilia O'Kane, Danny McAuley, Carlos Cordon-Cardo, Markus Maeurer

Research output: Contribution to journal › Editorial

31 Scopus citations

Fingerprint

Dive into the research topics of 'Reducing mortality and morbidity in patients with severe COVID-19 disease by advancing ongoing trials of Mesenchymal Stromal (stem) Cell (MSC) therapy — Achieving global consensus and visibility for cellular host-directed therapies'. Together they form a unique fingerprint.

Medicine & Life Sciences